Project Number 5R42AG044187-03 Agency/Funding Organization NIA Funding Year 2018 View Full Project Details for Commercialization of a Novel Therapeutic for Alzheimers Disease Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 4. Non-clinical Drug Development (small molecules and biologics) a. Amyloid beta Researcher and Organization Principal Investigator LOVELL, MARK ANTHONY Principal Investigator First Name MARK Principal Investigator Last Name LOVELL Awardee Organization COPLEX THERAPEUTICS, LLC Awardee State Kentucky Contact PI Country United States Project Detail Funding Opportunity Announcement PA-16-092: Small Business Alzheimer's Disease Research (R41/R42) FY Overall Cost $551,313 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official MARTIN, ZANE
